rs62636524
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_002617.4(PEX10):c.4del(p.Ala2ProfsTer10) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000011 in 1,364,232 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. A2A) has been classified as Likely benign.
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000011 ( 0 hom. )
Consequence
PEX10
NM_002617.4 frameshift
NM_002617.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.647
Genes affected
PEX10 (HGNC:8851): (peroxisomal biogenesis factor 10) This gene encodes a protein involved in import of peroxisomal matrix proteins. This protein localizes to the peroxisomal membrane. Mutations in this gene result in phenotypes within the Zellweger spectrum of peroxisomal biogenesis disorders, ranging from neonatal adrenoleukodystrophy to Zellweger syndrome. Alternative splicing results in two transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
?
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant located near the start codon (<100nt), not predicted to undergo nonsense mediated mRNA decay. There are 49 pathogenic variants in the truncated region.
PM2
?
Very rare variant in population databases, with high coverage;
PP5
?
Variant 1-2412498-GC-G is Pathogenic according to our data. Variant chr1-2412498-GC-G is described in ClinVar as [Pathogenic]. Clinvar id is 449304.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PEX10 | NM_002617.4 | c.4del | p.Ala2ProfsTer10 | frameshift_variant | 1/6 | ENST00000447513.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PEX10 | ENST00000447513.7 | c.4del | p.Ala2ProfsTer10 | frameshift_variant | 1/6 | 1 | NM_002617.4 | P4 |
Frequencies
GnomAD3 genomes ? AF: 0.0000132 AC: 2AN: 152016Hom.: 0 Cov.: 34
GnomAD3 genomes
?
AF:
AC:
2
AN:
152016
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000107 AC: 13AN: 1212216Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 8AN XY: 592076
GnomAD4 exome
AF:
AC:
13
AN:
1212216
Hom.:
Cov.:
31
AF XY:
AC XY:
8
AN XY:
592076
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.0000132 AC: 2AN: 152016Hom.: 0 Cov.: 34 AF XY: 0.0000135 AC XY: 1AN XY: 74280
GnomAD4 genome
?
AF:
AC:
2
AN:
152016
Hom.:
Cov.:
34
AF XY:
AC XY:
1
AN XY:
74280
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
PEX10-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 14, 2023 | The PEX10 c.4delG variant is predicted to result in a frameshift and premature protein termination (p.Ala2Profs*10). This variant along with another truncation variant in this gene was reported in an individual with Zellweger syndrome (Table 4, Steinberg et al 2004. PubMed ID: 15542397). This variant is reported in 0.0037% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/1-2343937-GC-G). Frameshift variants in PEX10 are expected to be pathogenic. This variant is interpreted as pathogenic. - |
Peroxisome biogenesis disorder 6A (Zellweger) Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Oct 12, 2023 | - - |
Peroxisome biogenesis disorder 6B Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | Counsyl | Mar 23, 2017 | - - |
Peroxisome biogenesis disorder, complementation group 7 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Aug 29, 2023 | This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ala2Profs*10) in the PEX10 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PEX10 are known to be pathogenic (PMID: 9683594, 10862081, 21031596). This premature translational stop signal has been observed in individual(s) with Zellweger syndrome spectrum (PMID: 15542397). ClinVar contains an entry for this variant (Variation ID: 449304). For these reasons, this variant has been classified as Pathogenic. - |
Zellweger spectrum disorders Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | May 15, 2017 | The c.4delG variant in the PEX10 gene has been reported previously in an individual with Zellwegersyndrome who also harbored a PEX10 nonsense variant, although parental studies were not performedto determine the phase of these two variants (Steinberg et al., 2004). One functional study indicatedthe c.4delG variant had 23% of PEX transcript in patient skin fibroblasts compared to healthycontrols (Dranchak et al., 2011). The c.4delG variant causes a frameshift starting with codon Alanine2, changes this amino acid to a Proline residue, and creates a premature Stop codon at position 10 ofthe new reading frame, denoted p.A2PfsX10. This variant is predicted to cause loss of normal proteinfunction either through protein truncation or nonsense-mediated mRNA decay. No data are availablefrom control populations to assess the frequency of this variant (Lek et al., 2016). We interpretc.4delG as a pathogenic variant. - |
Peroxisome biogenesis disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 29, 2022 | Variant summary: PEX10 c.4delG (p.Ala2ProfsX10) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 1.3e-05 in 150790 control chromosomes (gnomAD v3.1.2). c.4delG has been reported in the literature in at least one compound heterozygous individual affected with Zellweger Syndrome (e.g. Steinberg_2004, Yik_2009). One publication reports experimental evidence indicating that patient fibroblasts with this variant in compound heterozygosity with p.E298X have approximately 23% mutated PEX transcripts compared to healthy controls (Dranchak_2011). Four ClinVar submitters have assessed the variant since 2014: one classified the variant as likely pathogenic and three as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at